Intense exercise increases dopamine transporter and neuromelanin concentrations in the substantia nigra in Parkinson’s disease

Bart de Laat,Jocelyn Hoye,Gelsina Stanley,Michelle Hespeler,Jennifer Ligi,Varsha Mohan,Dustin W. Wooten,Xiaomeng Zhang,Thanh D. Nguyen,Jose Key,Giulia Colonna,Yiyun Huang,Nabeel Nabulsi,Amar Patel,David Matuskey,Evan D. Morris,Sule Tinaz

DOI: https://doi.org/10.1038/s41531-024-00641-1

2024-02-09

Abstract:Abstract Parkinson’s disease (PD) is characterized by a progressive loss of dopaminergic neurons. Exercise has been reported to slow the clinical progression of PD. We evaluated the dopaminergic system of patients with mild and early PD before and after a six-month program of intense exercise. Using 18 F-FE-PE2I PET imaging, we measured dopamine transporter (DAT) availability in the striatum and substantia nigra. Using NM-MRI, we evaluated the neuromelanin content in the substantia nigra. Exercise reversed the expected decrease in DAT availability into a significant increase in both the substantia nigra and putamen. Exercise also reversed the expected decrease in neuromelanin concentration in the substantia nigra into a significant increase. These findings suggest improved functionality in the remaining dopaminergic neurons after exercise. Further research is needed to validate our findings and to pinpoint the source of any true neuromodulatory and neuroprotective effects of exercise in PD in large clinical trials.

neurosciences

What problem does this paper attempt to address?

The problem that this paper attempts to solve is whether high - intensity exercise can improve the function of the dopamine system and slow down the clinical progress of the disease in patients with Parkinson's disease (PD). Specifically, the researchers evaluated the changes in dopamine transporter (DAT) availability and neuromelanin (NM) content in the substantia nigra in patients with mild and early - stage Parkinson's disease before and after six months of high - intensity exercise.

Research background:
- Parkinson's disease is a neurodegenerative disease characterized by the gradual loss of dopaminergic neurons.
- Exercise has been reported to slow down the clinical progress of Parkinson's disease.
- Animal model studies have shown that exercise can protect dopaminergic neurons, and this protective effect may be mediated by neurotrophic, anti - inflammatory and pro - angiogenic factors.
- In humans, indirect evidence suggests that exercise may be neuroprotective, but these potential effects have not been directly studied in living Parkinson's disease patients.

Research methods:
- Use 18F - FE - PE2I positron emission tomography (PET) imaging to measure DAT availability in the striatum and substantia nigra.
- Use NM - MRI to assess the neuromelanin content in the substantia nigra.
- Adopt quantitative susceptibility mapping (QSM) technology to exclude the potential confounding effect of iron deposition on NM measurement.

Research results:
- High - intensity exercise reversed the expected decline in DAT availability, causing it to increase significantly in the substantia nigra and putamen.
- High - intensity exercise also reversed the expected decline in neuromelanin concentration, causing it to increase significantly in the substantia nigra.

Research conclusions:
- These findings indicate that the function of the remaining dopaminergic neurons has been improved after exercise.
- The study supports the use of high - intensity exercise as part of the early - stage treatment plan for Parkinson's disease, and also suggests the possibility of exercise as an effective non - invasive neuromodulation therapy.
- In the future, more randomized controlled trials are needed to optimize exercise regimens and verify these observations and the mechanisms behind them.